Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.380 USD  +0.200 (+4.78%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about BioTime, Inc.
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Chief Medical Officer of BioTime’s Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China
October 22, 2009
from Business Wire News Releases
BioTime Investigating Stem Cells to Treat Cancer
October 22, 2009
BioTime, Inc. announced that Dr. David Jin, Chief Medical Officer of BioTime’s newly formed subsidiary, OncoCyte Corporation, will present the keynote address at the Fifth Chinese Congress on Stem Cell... Read More
from ChinaBio® Today
New BioTime Subsidiary, OncoCyte Corporation, Receives $2 Million Equity Financing to Develop Cancer Treatments Using Stem Cell Technology
October 15, 2009
from Business Wire News Releases
BioTime to Podcast Presentation at Annual Meeting of Shareholders
October 14, 2009
from Business Wire News Releases
The Week in Review: Three Life Science Companies to IPO on GEM
September 26, 2009
Three life science companies will IPO on Shenzhen’s Growth Enterprise Market (GEM), a new Nasdaq-like exchange; AMDL will spin off its China subsidiary Jade Pharma; BioTime will establish a China... Read More
from ChinaBio® Today
BioTime Announces China Stem Cell Subsidiary
September 23, 2009
BioTime, Inc. will establish a China subsidiary, called BioTime Asia, to market the company’s stem cell products in China and throughout Asia. The company will also seek to develop stem cell therapies... Read More
from ChinaBio® Today
BioTime, Inc. to Form Asian Subsidiary
September 22, 2009
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present Keynote Address at China-USA Scientific Forum of Stem Cell and Regenerative Medicine
September 18, 2009
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at 2009 World Stem Cell Summit
September 02, 2009
from Business Wire News Releases
BioTime, Inc. Completes Exchange Offer for Revolving Line of Credit Notes
August 24, 2009
from Business Wire News Releases
BioTime, Inc. Appoints Pedro Lichtinger to Its Board of Directors
August 17, 2009
from Business Wire News Releases
BioTime Appoints Walter Funk Vice President for Stem Cell Research
August 10, 2009
from Business Wire News Releases
BioTime, Inc. Commences Exchange Offer for Revolving Line of Credit Notes
August 05, 2009
from Business Wire News Releases
BioTime Investors Fund Second $4,000,000 Equity Tranche
July 13, 2009
from Business Wire News Releases
BioTime Announces Stem Cell Co-marketing Agreement with Millipore
July 09, 2009
from Business Wire News Releases
BioTime, Inc. Adds New Members to Its Board of Directors
July 07, 2009
from Business Wire News Releases
Market Pulse Announces Its Hot Stock Alerts for Thursday, May 14, 2009: MNGA, AMD, BTIM, MSFT
May 14, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse. Read More
from Marketwired News Releases
BioTime Raises $4,000,000 in Equity Financing
May 14, 2009
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009 and Discuss New Cell Lines with Cartilage-Forming Potential
May 07, 2009
from Business Wire News Releases
BioTime Awarded a $4.7 Million Research Grant from the California Institute for Regenerative Medicine
April 30, 2009
from Business Wire News Releases
BioTime Announces 2008 Year-End Results
March 30, 2009
from Business Wire News Releases
BioTime's Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
February 26, 2009
from Business Wire News Releases
Company Profile for BioTime, Inc.
January 23, 2009
category BioTime, Inc.
from Business Wire News Releases
BioTime Launches New Stem Cell Lines in Anticipation of President Obama’s Removal of Restrictions on Federal Funding of Embryonic Stem Cell Research
January 21, 2009
from Business Wire News Releases
BioTime Inc. Announces Third Quarter 2008 Financial Results
November 21, 2008
from Business Wire News Releases
BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Lette
November 19, 2008
from Business Wire News Releases
BioTime CEO Dr. Michael West Presents Keynote Address at Event Commemorating the 10th Anniversary of the First Derivation of Human Embryonic Stem Cells
November 14, 2008
from Business Wire News Releases
BioTime CEO Dr. Michael West Presents at GTCbio Advances in Stem Cell Discoveries Meeting and Announces Launch of New Neural Crest Cell Lines
October 27, 2008
from Business Wire News Releases
BioTime Announces Collaboration With the International Longevity Center on Regenerative Medicine
October 13, 2008
from Business Wire News Releases
BioTime CEO Dr. Michael West Presents at Tecan Symposium 2008
September 18, 2008
from Business Wire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here